reference/36562641

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/36562641

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	3377
issn	1582-1838 1582-4934
issueIdentifier	21
pageRange	3363-3377
publicationName	Journal of Cellular and Molecular Medicine
startingPage	3363
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_77a77af034be618cdbae7091df80427e
bibliographicCitation	Salimi A, Schemionek‐Reinders M, Huber M, Vieri M, Patterson JB, Alten J, Brümmendorf TH, Kharabi Masouleh B, Appelmann I. XBP1 promotes NRAS^G12D pre‐B acute lymphoblastic leukaemia through IL‐7 receptor signalling and provides a therapeutic vulnerability for oncogenic RAS. J Cellular Molecular Medi. 2023 Sep 27;27(21):3363–77. doi: 10.1111/jcmm.17904.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7bf56be834b26857e4c1e4b052445d18 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_33c0affb5844f95b42fadcc34157a9c1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d0bb0ce3a1525d6c3d4f62e077da18bf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_89aa40379f49ede791ad067985160c1a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b3fcd6d7761f4cd1d48b83cb13e1720f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7d9d8c63b24449e5c77257c907bed90d http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0009-0004-4306-1513 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b64afc1ad691ef7db33bd37021cca85e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0d3bfdb42009ef9e8f41ed449d279702
date	2023-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1111/jcmm.17904 https://pubmed.ncbi.nlm.nih.gov/PMC10623536 https://pubmed.ncbi.nlm.nih.gov/37753803
isPartOf	https://portal.issn.org/resource/ISSN/1582-1838 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/27035 https://portal.issn.org/resource/ISSN/1582-4934
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	XBP1 promotes NRASG12D pre‐B acute lymphoblastic leukaemia through IL‐7 receptor signalling and provides a therapeutic vulnerability for oncogenic RAS
discusses	http://id.nlm.nih.gov/mesh/M0469399 http://id.nlm.nih.gov/mesh/M0583291 http://id.nlm.nih.gov/mesh/M0328195 http://id.nlm.nih.gov/mesh/M000615358 http://id.nlm.nih.gov/mesh/M0013341
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D054198Q000235 http://id.nlm.nih.gov/mesh/D015452Q000235
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000071717Q000235 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D020558Q000235 http://id.nlm.nih.gov/mesh/D008565Q000235 http://id.nlm.nih.gov/mesh/D015398 http://id.nlm.nih.gov/mesh/D056811Q000235 http://id.nlm.nih.gov/mesh/D011905

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID22433

Total number of triples: 45.